AnalystsDylan DupuisDylan Dupuis's Stock Forecasts
AnalystsDylan Dupuis
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4065 out of 4560 analysts
Average Return
-17.86%
Win Rate
18%2 out of 11
Risk vs Reward
Poor
Good
Dylan Dupuis Analyst Color
Get additional color on Dylan Dupuis's coverage of popular stocks
Dylan Dupuis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $7.00 | +944.78% | Reinstates | 4 months ago |
Inventiva SaIVA | 2 | Strong Buy | $11.00 | +234.35% | Reiterates | 7 months ago |
Aslan Pharmaceuticals LtdASLN | 2 | Strong Buy | $15.00 | +3,098.29% | Reiterates | 8 months ago |
Terns Pharmaceuticals IncTERN | 3 | Strong Buy | $23.00 | +390.41% | Reiterates | 9 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $32.00 | -50.72% | Assumes | a year ago |
Unity Biotechnology IncUBX | 1 | Strong Buy | $10.00 | +571.14% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.